U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H22N2O3
Molecular Weight 302.3682
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CATRAMILAST

SMILES

COC1=CC=C(C=C1OCC2CC2)[C@H](C)CN3C=CNC3=O

InChI

InChIKey=ACBYRQONKZKIIY-GFCCVEGCSA-N
InChI=1S/C17H22N2O3/c1-12(10-19-8-7-18-17(19)20)14-5-6-15(21-2)16(9-14)22-11-13-3-4-13/h5-9,12-13H,3-4,10-11H2,1-2H3,(H,18,20)/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H22N2O3
Molecular Weight 302.3682
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Catramilast is imidazolone derivative patented by Janssen Pharmaceutica N.V. as PDE IV inhibitor for the treatment of allergic, atopic, and inflammatory diseases.

Originator

Approval Year

Substance Class Chemical
Record UNII
QVZ4XA556B
Record Status Validated (UNII)
Record Version